EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus

Lai Wang, Haoyuan Yin, Jiao Jiang, Qilin Li, Changxing Gao, Wenrui Li, Bo Zhang, Yue Xin, Hongyang Li, Ming Zhao, Qianjin Lu

Acta Pharmaceutica Sinica B · 2024-10 · 14 (10) · 4560-4576

DOI: 10.1016/j.apsb.2024.06.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2024-10. Verfasst von Lai Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tripterygium wilfordii Hook F (TWHF) is a traditional Chinese medicine widely used in the treatment of systemic lupus erythematosus (SLE), with triptolide (TP) as its main active ingredient. However, its side effects also induced by TP, especially hepatotoxicity and reproductive toxicity, largely limit its application in a subset of patients. Monoclonal antibodies (mAbs) developed for the treatment of SLE that deplete B cells by targeting B cell-expressing antigens, such as CD19, have failed in clinical trials, partly due to their poor efficacy in consuming B cells. Here, we report the development of a rationally designed antibody‒drug conjugate (ADC), CD19 mAb-TP conjugate, to alleviate the side effects of TWHF and simultaneously improve the therapeutic efficacy of CD19 mAb. The CD19 mAb-TP conjugate, which was named ADC-TP, selectively depleted B cell subsets both in vitro and in vivo and effectively alleviated disease symptoms in mouse lupus models with enhanced therapeutic efficacy than CD19 mAb and fewer side effects than TP. Our present study proposes a CD19 mAb‒TP conjugate strategy to mitigate the toxicity of TWHF while also enhancing the therapeutical efficacy of CD19 mAbs for the treatment of SLE, providing a feasible method for improving the current agents used for treating SLE.

Schlagwörter

Stichwörter der Autor:innen

Antibody‒drug conjugateB cellsCD19Reproductive toxicitySynergistic effectSystemic lupus erythematosusTargeted therapyTriptolide

Autor:innen und Institutionen

  • Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China.
  • Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing 210042, China.
  • Hunan Key Laboratory of Medical Epigenomics, the Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing 210042, China.

Zitieren

APA

Wang, L., Yin, H., Jiang, J., Li, Q., Gao, C., Li, W., Zhang, B., Xin, Y., Li, H., Zhao, M., & Lu, Q. (2024). A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus. Acta Pharmaceutica Sinica B, 14(10), 4560-4576. https://doi.org/10.1016/j.apsb.2024.06.024

Vancouver

Wang L, Yin H, Jiang J, Li Q, Gao C, Li W, et al. A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus. Acta Pharmaceutica Sinica B. 2024;14(10):4560-4576. doi:10.1016/j.apsb.2024.06.024

BibTeX
@article{Wang2024,
  author = {Wang, Lai and Yin, Haoyuan and Jiang, Jiao and Li, Qilin and Gao, Changxing and Li, Wenrui and Zhang, Bo and Xin, Yue and Li, Hongyang and Zhao, Ming and Lu, Qianjin},
  title = {A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2024},
  volume = {14},
  number = {10},
  pages = {4560--4576},
  doi = {10.1016/j.apsb.2024.06.024}
}
Kostenlos starten →